MedTrace Logo

Quality of Life in Lymphoma Patients One Year Post-chemotherapy

NCT04187118 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 600

Last updated 2023-09-21

No results posted yet for this study

Summary

Malignant lymphomas are considered as among the most chemo-sensitive cancers. ML are cured in more than 85% of patient, the majority with complete response. After this active phase of treatment, patients are in "after cancer period". Toulouse University Hospital developed since 2006 the Ambulatory Medical Assistance for After Cancer program on lymphoma patient. Ambulatory Medical Assistance for After Cancer is very efficient for detecting physical and psychological complications which impact quality of life. The investigators identified 22% of lymphoma patients who had a reduced quality of life one year after the end of chemotherapy. The present study aims to investigate the evolution of observed complications and identify cancer care pathway which decrease the quality of life reduction risk in patients one year after lymphoma chemotherapy.

Conditions

Interventions

OTHER

Quality of life

Quality of life one year post chemo-therapy

Sponsors & Collaborators

  • Force Hémato

    collaborator UNKNOWN

  • Hospitalidee

    collaborator UNKNOWN

  • University Hospital, Toulouse

    lead OTHER

Principal Investigators

  • Loïc YSEBAERT, MD, PhD · University Hospital, Toulouse

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-01-28
Primary Completion
2025-06-01
Completion
2025-06-30

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04187118 on ClinicalTrials.gov